Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-11-01

Clinical Trial Update: iTBS in MCI and Mild AD [NA]

View source ↗

Summary

A clinical trial is planned to evaluate intermittent theta burst stimulation (iTBS) in individuals with mild cognitive impairment and mild Alzheimer's disease; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Defense Medical Center, Taiwan | Conditions: Mild Cognitive Impairment (MCI), Mild Alzheimer Disease | NA | Status: NOT_YET_RECRUITING